Article Sidebar
Published:
Feb 2, 2017DOI:
10.4314/tjpr.v16i1.9Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Molecular docking and in silico ADMET studies of silibinin and glycyrrhetic acid anti-inflammatory activity
Abstract
Purpose: To use in silico docking analysis and ADMET prediction of silibinin and glycyrrhetic acid to determine their pharmacokinetic and pharmacodynamic properties as therapeutic molecules against inflammatory disorders.
Methods: The study utilized plant-derived compounds with known anti-inflammatory activity. Three important enzymes, including COX-2, 5β-reductase and phospholipase A2, that are involved in the mediation of inflammatory processes, were chosen as protein targets for the ligands (silibinin and glycyrrhetic acid). Q-Site Finder and admetSAR were employed for active site prediction and ADMET profile, respectively. Furthermore, protein-ligand complexes were visually inspected by LigPlot and Chimera.
Results: Post-docking analysis confirmed strong interaction of silibinin and glycyrrhetic acid with their respective targets. ADMET profiles for both compounds were very promising. Both ligands (silibinin and glycyrrhetic acid) showed strong binding energy for all three target proteins (-7.5 to -10.9 kcal/mol). Moreover, Asp347, Gln350, Gly354, Gln192, His351, Ser579 and Phe580 were the common interacting residues in the target proteins for both ligands.
Conclusion: Glycyrrhetic acid possesses superior ADMET profile to silibinin. Hydrophobic interactions between the two ligands (glycyrrhetinic acid and silibinin) and the three target proteins (COX-2, phospholipase A2 and 5β-reductase) are significant.
Keywords: Silibinin, Glycyrrhetic acid, ADMET, Docking studies, Phospholipase A2, COX-2, 5β-Reductase
